DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

Sanofi (ADR) (NYSE: SNY)

company name or ticker
Company Photos
(Click to zoom)

Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S.

Time to Buy Amgen After Newly Approved Drug?

Oncolytics' Reolysin Phase II Lung Cancer Study Enrolled

MannKind: The Stock Where Tomorrow Never Arrives

Trade-Ideas: Sanofi (SNY) Is Today's Pre-Market Mover With Heavy Volume Stock

Why Sanofi Deserves A Second Look

Bouncing Biotech? 3 Stocks To Buy

It may be time to consider buying Gilead Sciences, Celgene Corp, and Regeneron on sale.

What's Behind Sanofi's Afrezza Pediatric Study For MannKind?

The 3 Most Disappointing Drug Launches of All Time

Treatments with huge promise don't always pan out the way you'd expect.

Cardiovascular Radiance For Jardiance

See More Articles...